搜索结果: 1-15 共查到“ovarian cancer”相关记录26条 . 查询时间(0.098 秒)
Researchers Advance Technique To Detect Ovarian Cancer（图）
Researchers Advance Technique Detect Ovarian Cancer
font style='font-size:12px;'>
2017/12/19
Researchers at Rice University and the University of Texas MD Anderson Cancer Center have refined and, for the first time, run in vivo tests of a method that may allow nanotube-based probes to locate ...
Nutrient-wide association study of 57 foods/nutrients and epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study
nutrition ovarian cancer saturated fat serous prospective cohort diet
font style='font-size:12px;'>
2018/11/23
Background: Studies of the role of dietary factors in epithelial ovarian cancer (EOC) development have been limited, and no specific dietary factors have been consistently associated with EOC risk.
EARLY DETECTION OF OVARIAN CANCER USING GABOR WAVELET PHASE QUANTIZATION AND BINARY CODING
Ovarian cancer treatment
font style='font-size:12px;'>
2015/5/27
Ovarian cancer is the 5th most common cancer in women, but it is the most difficult to detect in its early stages. Early detection and treatment of ovarian cancer has been shown to increase the five y...
ROLE OF OVARIAN CANCER-INITIATING CELLS IN HIGH-GRADE SEROUS OVARIAN CARCINOGENESIS
Epigenetics DNA Methylation Carcinogenesis
font style='font-size:12px;'>
2015/5/26
A subpopulation of tumor cells known as ovarian cancer initiating cells (OCICs) have been shown to be the cells that propagate the tumor phenotype in ovarian cancer. Studies have showed that a very sm...
Mechanism of tissue transglutaminase upregulation and its role in ovarian cancer metastasis
tissue transglutaminase TGF-beta ovarian cancer
font style='font-size:12px;'>
2015/5/25
Ovarian cancer (OC) is a lethal disease due to metastasis and chemoresistance. Our laboratory previously reported that tissue transglutaminase (TG2) is overexpressed in OC and enhances OC peritoneal m...
New Method Increases Accuracy of Ovarian Cancer Prognosis and Diagnosis
Ovarian Cancer Prognosis Diagnosis
font style='font-size:12px;'>
2015/4/29
Mathematical Technique Reveals Predictive DNA Patterns That Other Methods Missed.Nearly anyone touched by ovarian cancer will tell you: it’s devastating. It’s bad enough that cancer in almost 80 perce...
Targeted therapies in ovarian cancer
Targeted therapies ovarian cancer
font style='font-size:12px;'>
2015/3/26
Epithelial ovarian cancer is a challenging disease to treat, with the majority of patients presenting with advanced disease. Despite aggressive surgical debulking and platinum-based chemotherapy, many...
Management of women at high familial risk for breast and ovarian cancer
high familial risk breast and ovarian cancer
font style='font-size:12px;'>
2015/3/24
Women with a strong family history of breast and/or ovarian cancer have a greatly increased risk for the development of these diseases. The key question for these women is what they can do to ameliora...
The integrated, multidisciplinary clinic: a new model for the ongoing management of women at high genetic risk for breast and ovarian cancer
risk management
font style='font-size:12px;'>
2015/3/18
An important minority of Australian women have a strong hereditary predisposition for the development of breast and/or
ovarian cancer. Evidence-based cancer risk reduction strategies for this group a...
MANAGEMENT OF WOMEN AT INCREASED GENETIC RISK OF OVARIAN CANCER
INCREASED GENETIC RISK MANAGEMENT
font style='font-size:12px;'>
2015/3/13
Epidemiological studies have identified family history as one of
the major risk factors for epithelial ovarian cancer (subsequently
referred to as “ovarian cancer”) and in recent years we have
gain...
MOLECULAR PROGNOSIS OF EPITHELIAL OVARIAN CANCER: OBSERVATIONS FROM CURRENT LITERATURE
MOLECULAR PROGNOSIS CANCER
font style='font-size:12px;'>
2015/3/13
The most effective
chemotherapy agent against ovarian cancer is cisplatin – also
used for lung, head and neck, bladder and testicular cancers.
Response rates to this drug vary from 40%-80% and it i...
Screening in ovarian cancer
ovarian cancer world
font style='font-size:12px;'>
2015/3/13
Ovarian cancer is the leading cause of death from
gynaecological cancer in the developed world, comprising 5%
of all cancer-related deaths in women. The high mortality rate
has been attributed prim...
THE NATIONAL OVARIAN CANCER PROGRAM
CANCER PROGRAM NATIONAL
font style='font-size:12px;'>
2015/3/13
Ovarian cancer is the leading cause of death from
gynaecological cancers in Australia. In recognition of the
impact of ovarian cancer on Australian women, in September
2001 the Federal Government c...
RISK FACTORS FOR EPITHELIAL OVARIAN CANCER
RISK FACTORS OVARIAN CANCER
font style='font-size:12px;'>
2015/3/13
Although in Australia the lifetime risk of ovarian cancer is only
one in 107, it is the fifth most common cause of cancer death in
Australian women1
. Over 90% of ovarian malignancies are
thought ...
Knockdown of the DNA repair and redox signaling protein Ape1/ Ref-1 blocks ovarian cancer cell and tumor growth
base excision repair APE1/Ref-1 ovarian cancer
font style='font-size:12px;'>
2014/12/12
Apurinic endonuclease 1/redox effector factor-1 (Ape1/Ref-1 or Ape1) is an essential protein with two distinct functions. It is a DNA repair enzyme in the base excision repair (BER) pathway and a redu...